One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs ...

Adults with obesity receiving once-weekly semaglutide 7.2 mg lost a higher proportion of their body weight at 72 weeks than ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

Eli Lilly's diverse portfolio shows broad growth, with significant contributions from oncology and other therapeutic areas.

The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity ...

Selective stock-picking and conviction drove HB Biotech’s strong 2024 performance. Read our insights on navigating today’s ...

Official data shows that since 2019, this medication has been linked to 23 deaths and 1,179 serious adverse reactions in the ...

FAT loss jabs have been spotted being flogged for £40 on TikTok as hundreds of Brits have been hospitalised with “serious ...

Weight loss jabs are now are now available on the NHS for those with a prescription. But a black market for the in-demand ...

Novo is currently in a golden age of growth. Over the last five years, its trailing-12-month revenue grew by 109%, reaching ...

Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new ...